| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Tiwari is Mathematical Statistician and Program Director, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD.
Dr. Ghosh is Assistant Professor, Department of Statistics, George Washington University, Washington, DC.
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Hackey is Statistical Programmer, Information Management Services Inc., Silver Spring, MD.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Feuer is Chief, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD.
Every January for more than 40 years, the American Cancer Society (ACS) has estimated the total number of cancer deaths that are expected to occur in the United States and individual states in the upcoming year. In a collaborative effort to improve the accuracy of the predictions, investigators from the National Cancer Institute and the ACS have developed and tested a new prediction method. The new method was used to create the mortality predictions for the first time in Cancer Statistics, 2004 and Cancer Facts & Figures 2004. The authors present a conceptual overview of the previous ACS method and the new state-space method (SSM), and they review the results of rigorous testing to determine which method provides more accurate predictions of the observed number of cancer deaths from the years 1997 to 1999. The accuracy of the methods was compared using squared deviations (the square of the predicted minus observed values) for each of the cancer sites for which predictions are published as well as for all cancer sites combined. At the national level, the squared deviations were not consistently lower for every cancer site for either method, but the average squared deviations (averaged across cancer sites, years, and sex) was substantially lower for the SSM than for the ACS method. During the period 1997 to 1999, the ACS estimates of deaths were usually greater than the observed numbers for all cancer sites combined and for several major individual cancer sites, probably because the ACS method was less sensitive to recent changes in cancer mortality rates (and associated counts) that occurred for several major cancer sites in the early and mid 1990s. The improved accuracy of the new method was particularly evident for prostate cancer, for which mortality rates changed dramatically in the late 1980s and early 1990s. At the state level, the accuracy of the two methods was comparable. Based on these results, the ACS has elected to use the new method for the annual prediction of the number of cancer deaths at the national and state levels.
This article has been cited by other articles:
|
|
 |
|
  A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M. J. Thun Cancer Statistics, 2008 CA Cancer J Clin, February 20, 2008; (2008) CA.2007.0010v1. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. P. Lopez, J. Wang-Rodriguez, C. Chang, J. S. Chen, F. S. Pardo, J. Aguilera, and W. M. Ongkeko Gefitinib Inhibition of Drug Resistance to Doxorubicin by Inactivating ABCG2 in Thyroid Cancer Cell Lines Arch Otolaryngol Head Neck Surg, October 1, 2007; 133(10): 1022 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Pickle, Y. Hao, A. Jemal, Z. Zou, R. C. Tiwari, E. Ward, M. Hachey, H. L. Howe, and E. J. Feuer A New Method of Estimating United States and State-level Cancer Incidence Counts for the Current Calendar Year CA Cancer J Clin, January 1, 2007; 57(1): 30 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun Cancer Statistics, 2007 CA Cancer J Clin, January 1, 2007; 57(1): 43 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Smigal, A. Jemal, E. Ward, V. Cokkinides, R. Smith, H. L. Howe, and M. Thun Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, May 1, 2006; 56(3): 168 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. J. Thun Cancer statistics, 2006. CA Cancer J Clin, March 1, 2006; 56(2): 106 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Badruddoja Size of Breast Cancer Tumor After Core-Needle Biopsy and Fine-Needle Aspiration Does Not Affect Patient Treatment Plan Arch Surg, October 1, 2005; 140(10): 1008 - 1009. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Bucci, A. Bevan, and M. Roach III Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond CA Cancer J Clin, March 1, 2005; 55(2): 117 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun Cancer Statistics, 2005 CA Cancer J Clin, January 1, 2005; 55(1): 10 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. J. Semmes, Z. Feng, B.-L. Adam, L. L. Banez, W. L. Bigbee, D. Campos, L. H. Cazares, D. W. Chan, W. E. Grizzle, E. Izbicka, et al. Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility Clin. Chem., January 1, 2005; 51(1): 102 - 112. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
